SOUTH AFRICA

Scourguard® 4KC

Reg. No.: G3841 (Act 36/1947)

  • For animal use only.

Expand All
    • ScourGuard® 4KC contains a liquid preparation of inactivated bovine-rotavirus (serotypes G6 and G10) and coronavirus propagated on established cell lines, a K99 E. coli bacterin and CI. perfringens type C toxoid. The vaccine is adjuvanted to enhance the immune response.

    • ScourGuard® 4KC is for vaccination of healthy, pregnant cows and heifers as an aid in preventing diarrhoea in their calves caused by bovine-rotavirus (serotypes G6 and G10), bovine coronavirus, enterotoxigenic strains of Escherichia coli having the K99 pili adherence factor, and Clostridium perfringens type C.
  • Use only as directed.

    • General Directions: Vaccination of healthy, pregnant cows and heifers is recommended. Shake well. Aseptically administer 2 ml intramuscularly (IM) only, in the muscular region of the neck.
    • Primary Vaccination: Administer 2 (two) IM X 2 ml doses approximately 3 weeks apart to pregnant cows and heifers, with the second dose given 3 to 6 weeks before calving.
    • Revaccination: Revaccination with a single dose 3 to 6 weeks before each subsequent calving is recommended.
    • Good animal husbandry and herd health practices, including annual revaccination, should be employed.
    • Do not vaccinate within 21 days before slaughter.
    • Keep out of reach of children, uninformed persons and animals.
    • Transient temperature increase may occur following vaccination.
    • As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.
    • This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions.
    • Although this vaccine has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspect, seek veterinary advice and notify the registration holder.
    • Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency.
    • Do not freeze. Use entire contents when first opened.
    • Sterilized syringes and needles should be used to administer this vaccine. Do not sterilise with chemicals because traces of disinfectant may inactivate the vaccine.
    • Burn containers and all unused contents.
    • Contains gentamicin and merthiolate as preservatives.
    • Store at 2 °C - 7 °C. Prolonged exposure may adversely affect potency.
    • Do not freeze.
    • A carton containing 10 dose (20 ml) vials of vaccine.

DISCLAIMER: ALTHOUGH GREAT CARE HAS BEEN TAKEN IN THE COMPILATION OF THIS DOCUMENT, READERS ARE REQUESTED TO REFER TO THE PACKAGE INSERT FOR COMPLETE DETAILS BEFORE USING THE SPECIFIC PRODUCT.

Ordering Products

Fax no. for Orders:
+27 21 427 6442
 
Email address for Orders:
ZoetisOrders@zoetis.com
 
Physical Address:
Zoetis South Africa (Pty) Ltd.
Co. Reg. No.: 2012/001825/07
6th Floor, North Wing, 90 Rivonia Road, Sandton, 2196.
 
Tel:
+27 11 245 3300 or 0860 ZOETIS (0860 963847)

Terms of sale

Postal Address

Zoetis South Africa (Pty) Ltd
PostNet Suite 53
Private Bag 9976
Sandton
2146